ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Biopharma Credit Plc

Biopharma Credit Plc (BPCR)

0.87
0.00
(0.00%)
Closed July 16 11:30AM

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
0.87
Bid
0.87
Ask
0.874
Volume
0.00
0.00 Day's Range 0.00
0.81 52 Week Range 0.942
Market Cap
Previous Close
0.87
Open
-
Last Trade
(O)
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
1,677,730
Shares Outstanding
1,253,637,845
Dividend Yield
6.03%
PE Ratio
7.86
Earnings Per Share (EPS)
0.09
Revenue
135.74M
Net Profit
108.45M

About Biopharma Credit Plc

Sector
Finance Services
Industry
Finance Services
Headquarters
London, Ontario, Can
Founded
1970
Biopharma Credit Plc is listed in the Finance Services sector of the London Stock Exchange with ticker BPCR. The last closing price for Biopharma Credit was $0.87. Over the last year, Biopharma Credit shares have traded in a share price range of $ 0.81 to $ 0.942.

Biopharma Credit currently has 1,253,637,845 shares outstanding. The market capitalization of Biopharma Credit is $1.09 billion. Biopharma Credit has a price to earnings ratio (PE ratio) of 7.86.

BPCR Latest News

BioPharma Credit PLC UPDATE ON INVESTMENT

BioPharma Credit PLC 01 July 2024   1 July 2024   BIOPHARMA CREDIT PLC   UPDATE ON INVESTMENT   BioPharma Credit PLC (LSE: BPCR) (the "Company") makes reference to its announcements on (i) 2...

BioPharma Credit PLC Net Asset Value(s) and Monthly Factsheet

BioPharma Credit PLC 21 June 2024   BIOPHARMA CREDIT PLC (the 'Company')   As at the 31 May 2024 the unaudited net asset value per Ordinary Share, including current period revenue, was 100.11...

BioPharma Credit PLC Dividend Declaration

BioPharma Credit PLC 20 June 2024   BioPharma Credit PLC 20 June 2024   BIOPHARMA CREDIT PLC  ("BIOPHARMA CREDIT" OR THE "COMPANY")  DIVIDEND DECLARATION BioPharma Credit PLC (LSE: BPCR), the...

BioPharma Credit PLC Result of AGM

BioPharma Credit PLC 12 June 2024   BIOPHARMA CREDIT PLC   (THE "COMPANY")     RESULT OF 2024 ANNUAL GENERAL MEETING   The Company is pleased to announce that, at the Annual General Meeting...

BioPharma Credit PLC Total Voting Rights

BioPharma Credit PLC 03 June 2024   BioPharma Credit plc (the "Company") TOTAL VOTING RIGHTS   In conformity with the Disclosure Guidance and Transparency Rules, the Company's issued share...

BioPharma Credit PLC UPDATE ON INVESTMENT

BioPharma Credit PLC 28 May 2024   28 May 2024   BIOPHARMA CREDIT PLC   UPDATE ON INVESTMENT   BioPharma Credit PLC (LSE: BPCR) notes the update on the UK CMA (Competition and Markets...

BioPharma Credit PLC Net Asset Value(s) and Monthly Factsheet

BioPharma Credit PLC 22 May 2024   BIOPHARMA CREDIT PLC (the 'Company')   As at the 30 April 2024 the unaudited net asset value per Ordinary Share, including current period revenue, was 98.98...

BioPharma Credit PLC Director/PDMR Shareholding

BioPharma Credit PLC 13 May 2024   BIOPHARMA CREDIT PLC   Notification of Transactions by Persons Discharging Managerial Responsibilities and Persons Closely Associated with them   1. Details...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.0182.112676056340.8520.8760.85212036860.87DE
40.0263.080568720380.8440.8760.8318767700.84489541DE
12-0.006-0.6849315068490.8760.8860.8316777300.85838482DE
26-0.066-7.051282051280.9360.9420.8317156270.8830255DE
52-0.014-1.583710407240.8840.9420.8116189310.87156473DE
156-0.096-9.937888198760.9661.050.8117660540.93553325DE
260-0.185-17.53554502371.0551.0550.8115068750.95112138DE

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
AMIXAutonomix Medical Inc
$ 1.3701
(121.70%)
154.81M
SHOTWSafety Shot Inc
$ 0.41
(115.79%)
7.56k
DATSDatChat Inc
$ 1.89
(81.73%)
54.75M
CYNCYNGN Inc
$ 9.18
(53.77%)
17.79M
SCNIScinai Immunotherapeutics Ltd
$ 5.80
(42.86%)
29.37M
ASLNASLAN Pharmaceuticals Ltd
$ 1.36
(-46.67%)
1.16M
KZIAKazia Therapeutics Ltd
$ 0.5593
(-37.56%)
15.34M
LCFYLocafy Ltd
$ 3.5597
(-36.32%)
584.38k
NAASNaaS Technology Inc
$ 2.82
(-33.02%)
1.94M
ZENVZenvia Inc
$ 1.67
(-26.75%)
658.26k
FFIEFaraday Future Intelligent Electric Inc
$ 0.5152
(22.09%)
217.92M
NVDANVIDIA Corporation
$ 128.44
(-0.62%)
208.32M
SQQQProShares UltraPro Short QQQ
$ 7.46
(-0.67%)
155.14M
AMIXAutonomix Medical Inc
$ 1.3701
(121.70%)
154.81M
TSLATesla Inc
$ 252.64
(1.78%)
147.31M

Discussion

View Full Feed
PickStocks PickStocks 5 minutes ago
Yes…and he also said real soon months ago
COOP
Fdc4 Fdc4 14 minutes ago
I guess you are about to have some proof of your own by now. Ouch… Averaging down now, right? Buying the cheapies
IGPK
GVInvestments GVInvestments 16 minutes ago
I'm holding till $300.00 per share.
FNMA
HippyTrades HippyTrades 16 minutes ago
Your head is literally spinning because you know that was a horrible annual report and you can't face it
AXXA
vinmantoo vinmantoo 18 minutes ago
No data on clinical endpoints.

Thanks for the link. Pretty telling that they didn't include symptom relief data.
HippyTrades HippyTrades 19 minutes ago
The buyback fund?
Wow do you ever make stuff up.
What do you think a disclosure is?
AXXA
DocLee DocLee 21 minutes ago
In "Nature", (12th July) another effective treatment (Car-T) for brain tumours (this time in children) which might complement DCVax (and would be less toxic). The article is at https://www.nature.com/articles/d41586-024-02255-2?utm_source=Live+Audience&utm_campaign=f8586bf0ce-nature-briefing-daily
NWBO
Wise Man Wise Man 26 minutes ago
Error in the hyperlink to the CFR 1229.13 posted before, that inserted a new capital distribution: the Lamberth rebate (Number 3), thanks to an express grant of authority of FHFA in the law to do it (Number 3 in the FHEFSSA definition of capital distribution, posted before).
Chevron deference
FNMA
nowwhat2 nowwhat2 28 minutes ago
1 HR LATER.......


https://investorshub.advfn.com/uimage/uploads/2024/7/16/qtmkceth_777_15_5d_945pm_chan_3500_Gee.jpg

1 HR LATER.......WHUMP !
https://investorshub.advfn.com/uimage/uploads/2024/7/16/facjveth_777_15_5d_1045pm_chan_3500_WHUMP.jpg
BTCUSD
nowwhat2 nowwhat2 29 minutes ago
1 HR LATER.......


https://investorshub.advfn.com/uimage/uploads/2024/7/16/qtmkceth_777_15_5d_945pm_chan_3500_Gee.jpg

1 HR LATER.......WHUMP !
https://investorshub.advfn.com/uimage/uploads/2024/7/16/facjveth_777_15_5d_1045pm_chan_3500_WHUMP.jpg
ETHUSD
Sltan Sltan 31 minutes ago
100X
RNVA
Sltan Sltan 32 minutes ago
I hope we see
0.01
Earnings results
Fusion
to divide
Million profits
Price 0.0001
Chance of achieving x100
🤑🤑🤑🤑🤑🤑
RNVA
sentiment_stocks sentiment_stocks 38 minutes ago
And if your feeling particularly brave, why not contact the Chair of the CHM ?..

p.mulholland@ucl.ac.uk

You know that it was Paul Mullholland who presented the DCVax-L P3 data results at New York Academy of Sciences in about an hour long presentation on May 20, 2023, ri
NWBO
cootcat cootcat 39 minutes ago
60f1 you just show up to let us know this is a scam. ARE you new or just a different name? But you are not the first to make that statement or that claim. One has to remember that this is micro penny stock. How many micro pennies stock are call scams and actual are?
ILUS
rikkie rikkie 43 minutes ago
Calimero !
LWLG
BugStrong BugStrong 46 minutes ago
Today we shall see how the flow is.
WDLF
LazyInvestor LazyInvestor 48 minutes ago
What do you mean? The only financial records they needed to be current were for the 10Q for Q1 which were due in May. Or am I missing something here?
BEGI
BugStrong BugStrong 51 minutes ago
I thought more info on the companies in the incubator would have been talked, more details.
WDLF
Louinjaxxx Louinjaxxx 52 minutes ago
Maybe you don't want the company to audit the lndustries the company is involved in because it could make the company a great find in OTCMarkets.

Maybe you don't like how the CEO is managing the company because you think you could do better (CEO- envy).
AXXA
Wise Man Wise Man 53 minutes ago
Summary of the current state of Fanniegate: Chevron deference🆚Rogues.

Justice Alito can't make laws. What he was doing with his opinion, was to endorse the Separate Account plan, whether he likes it or not. His spin isn't even taken into consideration: "Rehabilitate FnF in a w
FNMA
Twister Twister 54 minutes ago
Military AR perhaps brighter than events/delays have appeared!

Delayed acceptance, budgets and depth of product scope remain attractive.
Corporate belt tightening is very real and military training budget cuts likely to continue.

Seeing continued interest by othe
VTSI
Fdc4 Fdc4 57 minutes ago
I wouldn’t be surprised if it is higher. JFHE posted Q2 coming and strong. So, it shall be higher at least. What I don’t understand is why name change is taking too long
IGPK
Louinjaxxx Louinjaxxx 58 minutes ago
It depends...which do you prefer, 62 mil debt or 31 mil debt?
AXXA
conix conix 59 minutes ago
Things are really looking up for Biden to roll over Trump in November.

Stay Positive. Biden did GREAT in that Lester Holt interview this evening. Sharp as a tack.

spdpro spdpro 1 hour ago
D > interesting
In the "past" with StreetSmartPro you could do that with advanced brackets >

I'm looking at TOS Web now and do not see any way to do things outside
of 2 differing order trades on 2 trade tickets to accomplish your 1 goal >
Even with >>> And Or